Immix Biopharma Announces 50% Enrollment Milestone Surpassed in its ongoing relapsed/refractory AL Amyloidosis Clinical Trial, NEXICART-2 Biotech Investing
HCW Biologics, a Shareholder of Wugen, Congratulates Wugen on Its Recent Successful Equity Financing Biotech Investing
Anti-Aging Biotech Surges as $101M Competition Ignites Global Race Against Aging Demographics Biotech Investing
Cizzle Brands Launches CWENCH Hydration in 149 Locations of Loblaws, Zehrs and Real Canadian/Atlantic Superstore Biotech Investing
Gain Therapeutics Begins Its GT-02287 Phase 1b Extension Study in People with Parkinson's Disease Biotech Investing
Biogen to Acquire Alcyone Therapeutics, Expanding Drug Delivery Solution Portfolio for Key Product and Pipeline Candidates Biotech Investing
MiNK Therapeutics Appoints Dr. Terese C. Hammond to Accelerate iNKT Pipeline to Pivotal Development Biotech Investing
Evidence-Driven Outcomes and Clinical Innovation Highlight Covalon's Presence at the Association for Vascular Access 2025 Annual Meeting Biotech Investing
Greenwich LifeSciences Announces Expansion of Flamingo-01 Clinical Trial to Ireland Biotech Investing
Biogen Receives European Commission Approval for ZURZUVAE® , the First and Only Treatment Approved for Women with Postpartum Depression in Europe Biotech Investing
